Discontinued Operations (Tables)

9 Months Ended

Jun. 30, 2013

Discontinued Operations And Disposal Groups [Abstract]

Operating Results from Discontinued Operations

The following is a summary of the operating results of SurModics Pharmaceuticals discontinued operations for the three and nine months ended June 30, 2013 and 2012 (in thousands):

	Three months ended June 30,						Nine months ended June 30,
	2013			2012			2013			2012
Total revenue	$	—		$	—		$	—		$	5,311
Income from discontinued operations	$	136		$	—		$	1,151		$	2,309
Income tax provision		(183	)		(30	)		(516	)		(1,078	)
(Loss) income from discontinued operations, net of income taxes	$	(47	)	$	(30	)	$	635		$	1,231
Loss on sale of discontinued operations	$	—		$	(57	)	$	—		$	(1,691	)
Income tax (provision) benefit		—			(25	)		—			676
Loss on sale of discontinued operations, net of income taxes	$	—		$	(82	)	$	—		$	(1,015	)

Assets and Liabilities of Discontinued Operations

The major classes of assets and liabilities of discontinued operations as of June 30, 2013 and September 30, 2012 were as follows (in thousands):

	June 30, 2013		September 30, 2012
Accounts receivable, net	$	—	$	283
Other current assets		45		600
Current assets of discontinued operations		45		883
Total assets of discontinued operations	$	45	$	883
Other current liabilities payable	$	125	$	1,640
Current liabilities of discontinued operations		125		1,640
Total liabilities of discontinued operations	$	125	$	1,640